Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some ...
SAN DIEGO -- Benefits with empagliflozin (Jardiance) for cardiovascular and renal health linger for about a year after discontinuation, as off-drug follow-up from the EMPA-KIDNEY trial showed. During ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback